{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:06:12Z","timestamp":1779253572328,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022419","name":"National Institute for Health Research Southampton Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bbalip.2026.159731","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T08:01:16Z","timestamp":1770710476000},"page":"159731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Surfactant nebulization in severe COVID-19: Tracheal aspirate phospholipid turnover and metabolism"],"prefix":"10.1016","volume":"1871","author":[{"given":"Anthony D.","family":"Postle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard W.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grielof","family":"Koster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhuriben","family":"Panchal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewis","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratko","family":"Djukanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Brealey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.W.","family":"Grocott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahilanandan","family":"Dushianthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2026.159731_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110412","article-title":"Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-kb pathway deregulation: a physio-pathological theory","volume":"146","author":"Carcaterra","year":"2021","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bbalip.2026.159731_bb0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2026.159731_bb0015","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1473-3099(20)30434-5","article-title":"Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-Centre descriptive study","volume":"20","author":"Carsana","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbalip.2026.159731_bb0020","first-page":"L367","article-title":"Surfactant phospholipids: synthesis and storage","volume":"262","author":"Batenburg","year":"1992","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.bbalip.2026.159731_bb0025","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1164\/ajrccm.153.1.8542113","article-title":"Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema","volume":"153","author":"G\u00fcnther","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbalip.2026.159731_bb0030","first-page":"L115","article-title":"Thoughts on the alveolar phase of COVID-19","volume":"319","author":"Mason","year":"2020","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.bbalip.2026.159731_bb0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12931-020-01603-w","article-title":"Surfactant therapy for COVID-19 related ARDS: a retrospective case-control pilot study","volume":"22","author":"Piva","year":"2021","journal-title":"Respir. Res."},{"key":"10.1016\/j.bbalip.2026.159731_bb0040","article-title":"Surfactant therapy using vibrating-mesh nebulizers in adults with COVID-19-induced ARDS: a case series","volume":"12","author":"Briones-Claudett","year":"2024","journal-title":"SAGE Open Med. Case Rep."},{"key":"10.1016\/j.bbalip.2026.159731_bb0045","doi-asserted-by":"crossref","first-page":"20946","DOI":"10.1038\/s41598-023-47672-x","article-title":"A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial)","volume":"13","author":"Dushianthan","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2026.159731_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12890-018-0761-y","article-title":"Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials","volume":"19","author":"Meng","year":"2019","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.bbalip.2026.159731_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/cc11512","article-title":"Clinical review: Exogenous surfactant therapy for acute lung injury\/acute respiratory distress syndrome--where do we go from here?","volume":"16","author":"Dushianthan","year":"2012","journal-title":"Crit. Care"},{"key":"10.1016\/j.bbalip.2026.159731_bb0060","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJM199605303342201","article-title":"Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf acute respiratory distress syndrome Sepsis study group","volume":"334","author":"Anzueto","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2026.159731_bb0065","article-title":"Breath-synchronized nebulized surfactant in a porcine model of acute respiratory distress syndrome","volume":"3","author":"DiBlasi","year":"2021","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.bbalip.2026.159731_bb0070","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1186\/s13063-020-04944-5","article-title":"Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-surf): a structured summary of a study protocol for a randomized controlled trial","volume":"21","author":"Dushianthan","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.bbalip.2026.159731_bb0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2466-14-10","article-title":"Phospholipid composition and kinetics in different endobronchial fractions from healthy volunteers","volume":"14","author":"Dushianthan","year":"2014","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.bbalip.2026.159731_bb0080","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/ajcn\/nqaa207","article-title":"Postnatal adaptations of phosphatidylcholine metabolism in extremely preterm infants: implications for choline and PUFA metabolism","volume":"112","author":"Goss","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbalip.2026.159731_bb0085","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12931-014-0128-8","article-title":"Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome","volume":"15","author":"Dushianthan","year":"2014","journal-title":"Respir. Res."},{"key":"10.1016\/j.bbalip.2026.159731_bb0090","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/ajrccm.152.3.7663782","article-title":"Pharmacokinetics of bovine surfactant in neonatal respiratory distress syndrome","volume":"152","author":"Griese","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbalip.2026.159731_bb0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/14767050410001668266","article-title":"Randomized clinical trial comparing two natural surfactant preparations to treat respiratory distress syndrome","volume":"15","author":"Hammoud","year":"2004","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.bbalip.2026.159731_bb0100","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1164\/rccm.202110-2279LE","article-title":"Rapid phospholipid turnover after surfactant nebulization in severe COVID-19 infection: a randomized clinical trial","volume":"205","author":"Postle","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbalip.2026.159731_bb0105","article-title":"Circulating microparticles in the pathogenesis and early anticoagulation of thrombosis in COVID-19 with kidney injury","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbalip.2026.159731_bb0110","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bbalip.2012.11.009","article-title":"Regulation of lung surfactant phospholipid synthesis and metabolism","volume":"1831","author":"Goss","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2026.159731_bb0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1465-9921-8-13","article-title":"Surfactant disaturated-phosphatidylcholine kinetics in acute respiratory distress syndrome by stable isotopes and a two compartment model","volume":"8","author":"Cogo","year":"2007","journal-title":"Respir. Res."},{"key":"10.1016\/j.bbalip.2026.159731_bb0120","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1542\/peds.49.3.464a","article-title":"The lecithin-sphingomyelin ratio of amniotic fluid: an index of fetal lung maturity?","volume":"49","author":"Roux","year":"1972","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbalip.2026.159731_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1465-9921-12-36","article-title":"Disaturated-phosphatidylcholine and surfactant protein-B turnover in human acute lung injury and in control patients","volume":"12","author":"Simonato","year":"2011","journal-title":"Respir. Res."},{"key":"10.1016\/j.bbalip.2026.159731_bb0130","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1172\/JCI3236","article-title":"Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein a-phospholipase A2 protein interaction","volume":"102","author":"Arbibe","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2026.159731_bb0135","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1194\/jlr.M085431","article-title":"Metabolism of a synthetic compared with a natural therapeutic pulmonary surfactant in adult mice","volume":"59","author":"Madsen","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2026.159731_bb0140","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1016\/j.bpj.2025.09.028","article-title":"Biohysical mechanisms of SARS-COV-2-induced surfactant inhibition","volume":"123","author":"Li","year":"2025","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbalip.2026.159731_bb0145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1165\/rcmb.2020-0335OC","article-title":"Dietary carbohydrates and fat induce distinct surfactant alterations in mice","volume":"64","author":"Schipke","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbalip.2026.159731_bb0150","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.chemphyslip.2011.04.004","article-title":"Analysis of lung surfactant phosphatidylcholine metabolism in transgenic mice using stable isotopes","volume":"164","author":"Postle","year":"2011","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bbalip.2026.159731_bb0155","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI38061","article-title":"LPCAT1 regulates surfactant phospholipid synthesis and is required for transitioning to air breathing in mice","volume":"120","author":"Bridges","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2026.159731_bb0160","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.2147\/JIR.S435305","article-title":"Association of sTREM-1 and neutrophil-to-lymphocyte ratio as prognostic markers in COVID-19 short- and long-yerm mortality","volume":"16","author":"Turgunova","year":"2023","journal-title":"J. Inflamm. Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138819812600017X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138819812600017X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:08:46Z","timestamp":1779250126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138819812600017X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S138819812600017X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2026.159731","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surfactant nebulization in severe COVID-19: Tracheal aspirate phospholipid turnover and metabolism","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2026.159731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"159731"}}